Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Malignant Pleural Effusion Market Grown from 2024 to 2025?

There has been substantial growth in recent years in the market for malignant pleural effusion. The market is projected to expand from $4.42 billion in 2024 to $4.74 billion in 2025, marking a compound annual growth rate (CAGR) of 7.1%. The past growth trend can be tied to factors such as the rising adoption of indwelling pleural catheters, amplified focus on palliative care, increased clinical trials, enhanced reimbursement, and an increase in metastatic malignancies.

What Growth Rate Is Anticipated for the Malignant Pleural Effusion Market in the Coming Years?

The market for malignant pleural effusion is projected to experience robust expansion in the forthcoming years. It is anticipated to escalate to $6.17 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.8%. The surge during the projection period can be credited to improvements in healthcare facilities, increased government backing, a growing number of cancer survivors, an amplified need for home-based care, and expansion in liquid biopsy. The predicted period is expected to witness major developments such as the infusion of artificial intelligence in imaging instruments, advancements in cancer-specific therapies, progress in pleurodesis, enhancement in biomarkers, and broadened clinical tests for new therapeutic agents.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22047&type=smp

Who Are the Leading Companies in the Malignant Pleural Effusion Market?

Major companies operating in the malignant pleural effusion market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Bristol-Myers Squibb Company, Gilead Sciences Inc., Amgen Inc., Medline Industries LP, Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc., Argon Medical Devices Inc., B Braun SE, Simcere Pharmaceutical Group Limited, pfm medical AG, Redax SpA, Wuhan YZY Biopharma Co. Ltd., Rocket Medical plc, Genelux Corporation, Gongwin Biopharm Holdings Co. Ltd., Ewimed GmbH

What Are the Key Drivers of the Malignant Pleural Effusion Market?

The malignant pleural effusion market is anticipated to witness growth propelled by an increase in lung cancer incidents. Lung cancer is recognized as an uncontrolled expansion of unusual cells in the lungs, contributing to tumor formation and normal lung function disruption. The cases of lung cancer are increasing due to smoking and tobacco consumption. This long-term exposure to harmful chemicals from these sources causes lung tissue damage, triggers genetic mutations, and encourages cancer cell growth, heightening the risk of disease development. Malignant pleural effusion is indicative of advanced lung cancer by promoting tumor growth within the pleural cavity, which further impairs respiratory function and worsens prognosis. For example, the American Cancer Society Facts and Figures reported that there were 236,740 new lung and bronchus cancer cases in 2022, and projected a rise to 238,340 cases in 2023. The death estimates were 130,180 in 2022, decreasing to 127,070 in 2023. Thus, the increase in lung cancer cases is leading to the growth of the malignant pleural effusion market. Advanced healthcare infrastructure is predicted to boost the malignant pleural effusion market. This term refers to the mandatory physical, technological, and organizational structures needed for health services provision, including manpower, IT systems, medical devices, clinics, and hospitals. The advancement in healthcare infrastructure is credited to the demand for improved disease control, contributing to heightened healthcare service accessibility, efficiency, and care quality. This progress enhances malignant pleural effusion’s diagnosis, treatment, and administration by facilitating access to avant-garde medical technologies, superior healthcare facilities, and specialized care, consequently improving patient results. As an example, the American Health Care Association indicated a 0.591% increase in US hospitals from 6,093 to 6,129 in May 2023. Hence, advancing healthcare infrastructure is adding to malignant pleural effusion market growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22047&type=smp

What Are the Key Market Segments in the Malignant Pleural Effusion Industry?

The malignant pleural effusion market covered in this report is segmented –

1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter

2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy

3) By End Users: Hospitals, Ambulatory Clinics, Other End Users

Subsegmentss:

1) By Systemic Therapy: Chemotherapy, Targeted Therapy, Immunotherapy

2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis

3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis, Mechanical Pleurodesis, Biological Pleurodesis

4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter

What Are the Latest Trends in the Malignant Pleural Effusion Market?

Key players in the malignant pleural effusion market are concentrating their efforts on creating novel therapies like enzyme-targeting therapy to enhance treatment outcomes by specifically targeting enzymes associated with fluid build-up. This therapeutic strategy, which involves the development of medicines or treatments that directly inhibit or alter the functionality of enzymes related to diseases, is frequently employed in cases such as cancer, metabolic disorders, and infectious diseases, where irregular enzyme activity plays a role in disease development. As an illustration, in September 2022, the US-based biotech firm, RS Oncology, LLC, commenced the MITOPE clinical trial – a pioneering Phase 1/2 trial in the UK. This is a Phase 1/2 research investigating RSO-021, a unique PRX3 inhibitor, developed for the treatment of malignant pleural effusion and mesothelioma, by focusing on oxidative stress to eradicate cancerous cells whilst preserving healthy tissue.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/malignant-pleural-effusion-global-market-report

What Are the Key Regional Markets in the Malignant Pleural Effusion Industry?

North America was the largest region in the malignant pleural effusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant pleural effusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22047

This Report Delivers Insight On:

1. How big is the malignant pleural effusion market, and how is it changing globally?

2. Who are the major companies in the malignant pleural effusion market, and how are they performing?

3. What are the key opportunities and risks in the malignant pleural effusion market right now?

4. Which products or customer segments are growing the most in the malignant pleural effusion market?

5. What factors are helping or slowing down the growth of the malignant pleural effusion market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model